Waters Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 12 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 395.61.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Waters Corp is 8.51, ranking 29 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 1.27B, representing a year-over-year increase of 91.48%, while its net profit experienced a year-over-year increase of 159.32%.
Key Metrics
The current valuation score of Waters Corp is 6.79, ranking 145 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 45.07, which is 0.00% below the recent high of 45.07 and 52.37% above the recent low of 21.46.
The current earnings forecast score of Waters Corp is 7.76, ranking 119 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 395.00, with a high of 460.00 and a low of 351.43.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Waters Corp is 9.59, ranking 8 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 379.02 and the support level at 309.22, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Waters Corp is 5.00, ranking 107 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 63.54%, representing a quarter-over-quarter decrease of 36.34%. The largest institutional shareholder is The Vanguard, holding a total of 7.22M shares, representing 7.35% of shares outstanding, with 39.63% decrease in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Waters Corp is 8.93, ranking 14 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.15. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
